Gan & Lee Showcases Metabolic Pipeline Data at ADA 2026
NEW ORLEANS, Louisiana, June 11, 2026 Gan & Lee Pharmaceuticals presented four significant research findings from its innovative metabolic...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
NEW ORLEANS, Louisiana, June 11, 2026 Gan & Lee Pharmaceuticals presented four significant research findings from its innovative metabolic...
MELBOURNE, Australia, June 11, 2026 Scientists have identified Lanthionine Synthetase C-Like Protein 1 (LANCL1) as a promising new therapeutic...
